Intravenous iron treatment in pregnancy: Comparison of high-dose ferric carboxymaltose vs. iron sucrose

Journal of Perinatal Medicine

Volumn 40, Issue 5, 2012, Pages 469-474

  Christoph, Patricia ^a   Schuller, Christine ^a   Studer, Hanna ^a   Irion, Olivier ^b   De Tejada, Begoña Martinez ^b   Surbek, Daniel ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Anemia; Ferric carboxymaltose; Hemoglobin; Intravenous iron therapy; Iron deficiency; Iron sucrose; Pregnancy; Safety; Tolerability

Indexed keywords

FERRIC CARBOXYMALTOSE; HEMOGLOBIN; IRON SACCHARATE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HEART PALPITATION; HIGH RISK PREGNANCY; HUMAN; HYPOTENSION; INJECTION SITE PAIN; INJECTION SITE RASH; INJECTION SITE REACTION; INJECTION SITE SWELLING; IRON DEFICIENCY ANEMIA; IRON THERAPY; MAJOR CLINICAL STUDY; NAUSEA; PREGNANCY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADULT; ANEMIA; FEMALE; FERRIC COMPOUNDS; GLUCARIC ACID; HEMATINICS; HUMANS; MALTOSE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84869431259     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/jpm-2011-0231     Document Type: Article

References (24)

1. Al RA, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A. Intravenous versus oral iron for treatment of anemia in pregnancy: A randomized trial. Obstet Gynaecol. 2005;106: 1335-40. (Pubitemid 41668954)
2. Al-Momen AK, Al-Meshari A, Al-Nuaim L, Saddique A, Abotalib Z, Khashogji T, et al. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1996;69:121-4. (Pubitemid 26338317)
3. Bailie GR. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: A review of randomized controlled trials across different indications. Arzneimittelforschung. 2010;60:386-98.
4. Bashiri A, Burstein E, Sheiner E, Mazor M. Anemia during pregnancy and treatment with intravenous iron: Review of the literature. Eur J Obstet Gynecol Reprod Biol. 2003;110:2-7. (Pubitemid 37025688)
5. Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxenaire MC. Iron therapy in iron deficiency anemia in pregnancy: Intravenous route versus oral route. Am J Obstet Gynecol. 2002;186:518-22. (Pubitemid 34234167)
6. Bencaiova G, von Mandach U, Zimmermann R. Iron prophylaxis in pregnancy: Intravenous route versus oral route. Eur J Obstet Gynecol Reprod Biol. 2009;144:135-9.
7. Breymann C, Gliga F, Bejenariu C, Strizhova N. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. Int J Gynaecol Obstet. 2008;101:67-73.
8. Breymann C, Honegger C, Holzgreve W, Surbek D. Diagnosis and treatment of iron-deficiency anaemia during pregnancy and postpartum. Arch Gynecol Obstet. 2010;282:577-80.
9. Institute of Medicine, Committee on Nutritional Status During Pregnancy and Lactation. Nutrition during pregnancy. Washington, DC: National Academy Press; 1990. p. 272-98.
10. Khalafallah A, Dennis A, Bates J, Bates G, Robertson IK, Smith L, et al. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. J Intern Med. 2010;268:286-95.
11. Klebanoff MA, Shiono PH, Selby JV, Trachtenberg AI, Graubard BI. Anemia and spontaneous preterm birth. Am J Obstet Gynecol. 1991;164:59-63.
12. Liberman E, Ryan KJ, Monson RR, Schooenbaum SC. Association of maternal hematocrit with premature labor. Am J Obstet Gynecol. 1988;139:107-14.
13. Lone FW, Qureshi RN, Emmanuel F. Maternal anemia and its impact on perinatal outcome in a tertiary care hospital in Pakistan. Eastern Mediterr Health J. 2004;10:801-7. (Pubitemid 41748914)
14. Lyseng-Williamson KA, Keating GM. Ferric carboxymaltose: A review of its use in iron-deficiency anaemia. Drugs. 2009;69:739-56.
15. Malek A. In vitro studies of ferric carboxymaltose on placental permeability using the dual perfusion model of human placenta. Arzneimittelforschung. 2010;60:354-61.
16. Milman N. Prepartum anaemia: prevention and treatment. Ann Hematol. 2008;87:949-59.
17. Puolakka J, Janne O, Vihko R. Serum ferritin in the diagnosis of anemia during pregnancy. Acta Obstet Gynecol Scand. 1980;95(Suppl):57-63.
18. Reveiz L, Gyte GML, Cuervo LG. Treatments for irondeficiency anaemia in pregnancy. Cochrane Database Syst Rev. 2007;18:CD003094. doi:10.1002/14651858. CD003094.pub2. (Pubitemid 351805940)
19. Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, Rogers R. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: A randomized controlled clinical trial. Am J Obstet Gynecol. 2008;199:435.e1 - e7.
20. Singh K, Fong YF, Kuperan P. A comparison between intravenous iron polymatose complex (ferrum Hausmann) and oral ferrous fumarate in the treatment of iron deficiency anaemia in pregnancy. Eur J Haematol. 1998;60:119-24. (Pubitemid 28082933)
21. Van Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: A randomized controlled trial. Obstet Gynecol. 2007;110:267-78. (Pubitemid 47356650)
22. Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia. Edited by Bruno de Benoist, Erin McLean, Ines Egli and Mary Cogswell.
23. World Health Organization. Nutritional anaemias. Tech Rep Ser. 1972;503.
24. World Health Organization. Preventing and controlling iron deficiency anemia through primary healthcare. Geneva; WHO 1989.